Kapitalo Investimentos’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Kapitalo Investimentos’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-87,881	Closed	-$2.12M	–	744
2023 Q1	$2.12M	Buy	+87,881	New	+$1.1M	0.69%	28

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Kapitalo Investimentos's PRVB Position: Q2 2023 in Review

Kapitalo Investimentos sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 87,881 shares — an estimated $2.12M sold.

Kapitalo Investimentos first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $2.12M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Kapitalo Investimentos reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Kapitalo Investimentos sold 87,881 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $2.12M.
Kapitalo Investimentos first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Kapitalo Investimentos's Provention Bio, Inc. Common Stock position peaked at $2.12M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Kapitalo Investimentos's 13F filing for Q2 2023, filed 29 Mar 2024.